These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Mobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats. Konagaya T; Bernsand M; Norlén P; Håkanson R Br J Pharmacol; 2001 May; 133(1):37-42. PubMed ID: 11325792 [TBL] [Abstract][Full Text] [Related]
44. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids. Azzoni C; Doglioni C; Viale G; Delle Fave G; De Boni M; Caruana P; Ferraro G; Bordi C Am J Surg Pathol; 1996 Apr; 20(4):433-41. PubMed ID: 8604810 [TBL] [Abstract][Full Text] [Related]
45. Diffuse enterochromaffin-like (ECL) cell hyperplasia and multiple gastric carcinoids: a complication of pernicious anaemia. Hodges JR; Isaacson P; Wright R Gut; 1981 Mar; 22(3):237-41. PubMed ID: 7227860 [TBL] [Abstract][Full Text] [Related]
46. Randomised trial of the effect of a gastrin/CCK Boyce M; van den Berg F; Mitchell T; Darwin K; Warrington S Eur J Clin Pharmacol; 2017 Feb; 73(2):129-139. PubMed ID: 27796466 [TBL] [Abstract][Full Text] [Related]
47. Gastric carcinoids after long-term use of a proton pump inhibitor. Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200 [TBL] [Abstract][Full Text] [Related]
50. Mutations of RegIalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia. Higham AD; Bishop LA; Dimaline R; Blackmore CG; Dobbins AC; Varro A; Thompson DG; Dockray GJ Gastroenterology; 1999 Jun; 116(6):1310-8. PubMed ID: 10348814 [TBL] [Abstract][Full Text] [Related]
51. Gastrin is the most important factor in ECL tumorigenesis. Waldum HL; Sandvik AK; Idle JR Gastroenterology; 1998 May; 114(5):1113-5. PubMed ID: 9606099 [No Abstract] [Full Text] [Related]